annb0t
Top 20
QuidelOrtho Corporation QDEL is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid preliminary revenue for fourth-quarter 2024, is expected to contribute further. However, risks due to overdependence on diagnostic tests and reimbursement policies persist.
This Zacks Rank #3 (Hold) company has gained 10.8% in the past six months compared with 15.9% growth of the industry. The S&P 500 has witnessed 10.6% growth in the said time...
>>> Read more: Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
This Zacks Rank #3 (Hold) company has gained 10.8% in the past six months compared with 15.9% growth of the industry. The S&P 500 has witnessed 10.6% growth in the said time...
>>> Read more: Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
